Prelude Capital Management, LLC Care Dx, Inc. Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $324,301 - $398,445	-10,502 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $105,778 - $197,770	5,582 Added 113.46%	10,502 $372,000
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $165,718 - $335,836	-11,888 Reduced 70.73%	4,920 $107,000
Q4 2019 Feb 14, 2020	SELL	$19.24 - $28.41 $39,307 - $58,041	-2,043 Reduced 10.84%	16,808 $363,000
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $221,672 - $443,565	-11,067 Reduced 36.99%	18,851 $426,000
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $289,019 - $445,861	11,211 Added 59.93%	29,918 $1.08 Million
Q1 2019 May 15, 2019	BUY	$22.09 - $39.21 $243,807 - $432,760	11,037 Added 143.9%	18,707 $590,000
Q4 2018 Feb 14, 2019	SELL	$19.89 - $30.02 $7,956 - $12,008	-400 Reduced 4.96%	7,670 $193,000
Q3 2018 Nov 14, 2018	SELL	$12.1 - $28.85 $345,455 - $823,667	-28,550 Reduced 77.96%	8,070 $233,000
Q2 2018 Aug 14, 2018	BUY	$7.93 - $15.79 $11,895 - $23,685	1,500 Added 4.27%	36,620 $448,000
Q1 2018 May 15, 2018	BUY	$5.18 - $7.97 $49,728 - $76,512	9,600 Added 37.62%	35,120 $280,000
Q4 2017 Feb 14, 2018	BUY	$3.98 - $7.37 $101,569 - $188,082	25,520	25,520 $187,000

215

50.9M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.25B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.